May 14, 2014

Arno Therapeutics to Outline Two Phase I Studies Evaluating Onapristone in Men’s and Women’s Cancers at 2014 ASCO Annual Meeting

May 14, 2014

Capricor Therapeutics to Hold First Quarter 2014 Business Update Conference Call on May 15, 2014 at 4:30 p.m. Eastern Time

May 6, 2014

Capricor Therapeutics Enters Into Exclusive License With Cedars-Sinai Medical Center for Exosome-Related IP Portfolio

May 5, 2014

Arno Therapeutics Announces Clinical Abstracts Accepted at 2014 ASCO Annual Meeting

April 14, 2014

Kite Pharma Expands Leadership Team and Announces Senior Management Promotions

April 11, 2014

Kite Pharma Expands Company’s Board of Directors with the Appointment of Jonathan M. Peacock

April 7, 2014

Arno Therapeutics Enrolls First Patient in a Phase I/II Trial Evaluating Onapristone in Men with Advanced Castration-Resistant Prostate Cancer

April 2, 2014

Kite Pharma Announces the Appointment of Arie Belldegrun, M.D., as President and Chief Executive Officer

April 1, 2014

Arno Therapeutics Reports 2013 Financial Results and Provides Update on Strategic and Operational Milestones

March 31, 2014

Kite Pharma Announces FDA Orphan Drug Designation for Anti-CD19 T Cell Cancer Immunotherapy Product

March 28, 2014

Capricor Therapeutics to Present ALLSTAR Phase I Trial Data at ACC Annual Meeting 2014

March 26, 2014

Arno Therapeutics to Present Three New Studies Supporting the Clinical Development of Onapristone at AACR Annual Meeting 2014

March 24, 2014

Arno Therapeutics Board of Directors Appoints Randy Thurman as Vice Chairman

March 10, 2014

Capricor Therapeutics to Present at Two Upcoming Investor Conferences

March 5, 2014

Arno Therapeutics to Present at 26th Annual ROTH Conference

March 4, 2014

Arno Therapeutics Granted Exclusive License for Oncology Diagnostic Technique by University of Minnesota

February 27, 2014

Arno Therapeutics Appoints Lawrence A. Kenyon Chief Financial Officer

January 21, 2014

Arno Therapeutics Enrolls First Patient in a Phase I Trial to Evaluate Lead Compound Onapristone in Progesterone Receptor Positive Solid Tumors

January 17, 2014

Kite Pharma Appoints Rizwana F. Sproule, Ph.D., as Vice President, Regulatory Affairs

January 13, 2014

Arno Therapeutics Expands Management Team with Additions of Two Scientific Leaders

January 9, 2014

Arno Therapeutics to Present at Biotech Showcase 2014

January 9, 2014

NeoStem’s Subsidiary, Progenitor Cell Therapy (PCT), to Provide Process Development and Manufacturing Services to Kite Pharma

January 8, 2014

Kite Pharma Appoints Cynthia M. Butitta as Chief Financial Officer

January 7, 2014

Arno Therapeutics Selects Leica Biosystems to Develop Companion Diagnostic for Targeted Oncology Therapy Onapristone

January 6, 2014

Capricor Therapeutics and Janssen Biotech, Inc. Enter Into Collaboration Agreement and Exclusive License Option